- Home
- ELVN vs WING Comparison
ELVN vs WING Comparison
Compare ELVN & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | WING |
|---|---|---|
| Founded | 2016 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.4B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ELVN | WING |
|---|---|---|
| Price | $41.19 | $121.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 28 |
| Target Price | $73.67 | ★ $196.08 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 11-11-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | 3.17 | ★ 67.84 |
| EPS | N/A | ★ 2.23 |
| Revenue | N/A | ★ $696,853,000.00 |
| Revenue This Year | N/A | $9.72 |
| Revenue Next Year | N/A | $15.86 |
| P/E Ratio | ★ N/A | $53.14 |
| Revenue Growth | N/A | ★ 11.35 |
| 52 Week Low | $14.79 | $95.82 |
| 52 Week High | $62.32 | $302.80 |
Technical Indicators
Market Signals| Indicator | ELVN | WING |
|---|---|---|
| Relative Strength Index (RSI) | 25.15 | 63.18 |
| Support Level | $38.58 | $116.35 |
| Resistance Level | $43.05 | $126.24 |
| Average True Range (ATR) | 1.88 | 4.82 |
| MACD | -0.38 | 2.60 |
| Stochastic Oscillator | 20.85 | 97.17 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About WING Wingstop Inc.
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.